References
- Aldskogius H, Kozlova EN. Central neuron-glial and glia-glial interactions following axon injury. Prog Neurobiol 55: 1- 26, 1998
- Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, Patel IR, Abramson SB. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Nat! Acad Sci USA 93: 14014-14019, 1996
- Aronson AL. Pharmacotherapeutics of the newer tetracyclines. J Am Vet Med Assoc 176: 1061-1068, 1980
- Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell 87: 13-20, 1996
- Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997
- Bennett GJ, Xie YK. A peripheral mononeuropathy and neuropathic pain behaviors following peripheral seen in man. Pain 33: 87 -107, 1998
- Bethea JR, Castro M, Keane RW, Lee TT, Dietrich WD, Yezierski RP. Traumatic spinal cord injury induces nuclear factor-kappaB activation. J Neurosci 18: 3251- 3260, 1998
- Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S, Bian J, Guo L, Farrell LA, Hersch SM, Hobbs W, Vonsattel JP, Cha JH, Friedlander RM. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med 6: 797 - 801, 2000
- Colburn RW, DeLeo JA, Rickman AJ, Yaeger MP, Kwon P, Hickey WF. Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J Neuroimmunol 79: 163-175, 1997
- Colburn RW, Rickman AJ, DeLeo JA. The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior. Exp Neurol 157: 289-304, 1999
- Coyle DE. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. Olia 23: 75- 83, 1998
- DeLeo JA, Yezierski RP. The role of neuroinflammation and neuroimmune activation in persistent pain. Pain 90: 1-6, 2001
- Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DL, Luecke S, Phebus LA, Bymaster FP, Paul SM. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Natl Acad Sci USA 98: 14669-14674, 2001
- Eriksson NP, Persson JK, Aldskogius H, Svensson M. A quantitative analysis of the astroglial cell reaction in primary sensory termination areas following sciatic nerve injury and treatment with nerve growth factor. Exp Brain Res 114: 393- 404, 1997
- Garrison CJ, Dougherty PM, Kajander KC, Carlton SM. Staining of glial fibrillary acidic protein (GFAP) in lumbar spinal cord increases following a sciatic nerve constriction injury. Brain Res 565: 1-7, 1991
- Gilmore SA, Sims YJ, Leiting JE. Astrocytic reactions in spinal gray matter following sciatic axotomy. Glia 3: 342-349, 1990
- Han HS, Yenari MA. Cellular targets of brain inflammation in stroke. Curr Opin Inuestig Drugs 4: 522-529, 2003
- Kaltschmidt C, Kaltschmidt B, Neumann H, Wekerle H, Baeuerle PA. Constitutive NF-kappa B activity in neurons. Mol Cell BioI 14: 3981- 3992, 1994
- Kreutzberg, GW. Microglia: a sensor for pathological events in the CNS, Trends Neurosci 19: 312-318, 1990
- Lee SJ, Lee S. Toll-like receptors and inflammation in the CNS. Curr Drug Targets Inflamm Allergy 1: 181-191, 2002
- Lin S, Zhang Y, Dodel R, Farlow MR, Paul SM, Du Y. Minocycline blocks nitric oxide-induced neurotoxicity by inhibition p38 MAP kinase in rat cerebellar granule neurons. Neurosci Lett 315: 6164, 2001
- Ma W, Bisby MA. Increased activation of nuclear factor kappa B in rat lumbar dorsal root ganglion neurons following partial sciatic nerve injuries. Brain Res 797: 243-254, 1998
- Meller ST, Dysktra C, Grzybycki D, Murphy S, Gebhart GF. The possible role of glia in nociceptive processing and hyperalgesia in the spinal cord of the rat. Neuropharmacology 33: 1471-1478, 1994
- Moore S, Thanos S. The concept of microglia in relation to central nervous system disease and regeneration. Prog Neurobiol 48: 441-460, 1996
- Nelissen I, Martens E, Van den Steen PE, Proost P, Ronsse I, Opdenakker G. Gelatinase B/matrix metalloproteinase-9 cleaves interferon-beta and is a target for immunotherapy. Brain 126: 1371- 1381, 2003
- 0' Neill LA, Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20:252-258, 1997
- Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306: 624-630, 2003
- Sadowski T, Steinmeyer J. Minocycline inhibits the production of inducible nitric oxide synthase in articular chondrocytes. J Rheumatol 28: 336- 340, 2001
- Sanchez Mejia RO, Ona VO, Li M, Friedlander RM. Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage and neurological dysfunction. Neurosurgery 48: 1393-1399, 2001
- Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J. Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation, proliferation of microglia. J Neurosci 21: 2580- 2588, 2001a
- Tikka TM, Koistinaho JE. Minocycline provides neuroprotection against N-methyl-D-aspartate neurotoxicity by inhibiting microglia. J Immunol 166: 7527 - 7533, 2001
- Tikka T, Usenius T, Tenhunen M, Keinanen R, Koistinaho J. Tetracycline derivatives and ceftriaxone, a cephalosporin antibiotic protect neurons against apoptosis induced by ionizing radiation. J Neurochem 78: 1409-1414, 2001b
- Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, Ferrante RJ, Kristal BS, Friedlander RM. Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington's disease. Proc Nat! Acad Sci USA 100: 10483 -10487, 2003
- Watkins LR, Maier SF. GLIA: A novel drug discovery target for clinical pain. Nat Rev Drug Discov 973-985, 2003
- Watkins LR, Martin D, Ulrich P, Tracey K, Maier SF. Evidence for the involvement of spinal cord glia in subcutaneous formalin induced hyperalgesia in the rat. Pain 71: 225- 235, 1997
- Watkins LR, Milligan ED, Maier SF. Spinal cord glia: new players in pain. Pain 93: 201- 205, 2001a
- Watkins LR, Milligan ED, and Maier SF. Glial activation: a driving force for pathological pain. Trends Neurosci 24: 450-455, 2001b
- Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, Choi D, Ischiropoulos H, Przedborski S. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine mouse model of Parkinson disease. J Neurosci 22: 1763-1771, 2002
- Ye SM, Johnson RW. Increased interleukin-6 expression by microglia from brain of aged mice. J Neuroimmunol 93: 139- 148, 1990
- Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Nat! Acad Sci USA 95: 15769-15774, 1998
- Zhang SC, Goetz BD, Duncan ID. Suppression of activated microglia promotes survival and function of transplanted oligodendroglial progenitors. Glia 41: 191-198, 2003
- Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110, 1983